Center for Scientific Review; Notice of Closed Meetings, 51280 [2010-20584]

Download as PDF 51280 Federal Register / Vol. 75, No. 160 / Thursday, August 19, 2010 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings emcdonald on DSK2BSOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Biology of Macromolecular Assemblies. Date: September 1, 2010. Time: 2 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Rolf Menzel, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD 20892, 301–435– 0952, menzelro@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cellular and Molecular Aspects of Neurodevelopment. Date: September 9, 2010. Time: 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Laurent Taupenot, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4811, MSC 7850, Bethesda, MD 20892, 301–435– 1203, taupenol@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Investigations on Primary Immunodeficiency Diseases. Date: September 28, 2010. Time: 11 a.m. to 5 pm. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Scott Jakes, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge VerDate Mar<15>2010 17:05 Aug 18, 2010 Jkt 220001 Drive, Room 4198, MSC 7812, Bethesda, MD 20892, 301–495–1506, jakesse@mail.nih.gov. Name of Committee: Immunology Integrated Review Group; Cellular and Molecular Immunology—A Study Section. Date: September 30–October 1, 2010. Time: 8:30 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: The St. Regis Washington, DC, 923 16th Street, NW., Washington, DC 20006. Contact Person: David B. Winter, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, Immunology IRG, 4th Floor, Rm. 4204, 6701 Rockledge Drive, RKII, Bethesda, MD 20892, 301–435–1152, dwinter@mail.nih.gov. Name of Committee: Immunology Integrated Review Group; Transplantation, Tolerance, and Tumor Immunology Study Section. Date: September 30–October 1, 2010. Time: 8:30 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: The Melrose Hotel, 2430 Pennsylvania Avenue, NW., Washington, DC 20037. Contact Person: Jin Huang, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4199, MSC 7812, Bethesda, MD 20892, 301–435–1230, jh377p@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Nonhuman Primate Core Humoral Immunology Vaccine Laboratory. Date: September 9, 2010. Time: 12:30 p.m. to 5:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Jay Bruce Sundstrom, PhD, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700B Rockledge Drvie, MSC–7616, Room 3119, Bethesda, MD 20892–7616, 301–496–2550, sundstromj@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 13, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–20612 Filed 8–18–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0274] Dated: August 10, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. Oversight of Laboratory Developed Tests; Public Meeting; Reopening of the Comment Period [FR Doc. 2010–20584 Filed 8–18–10; 8:45 am] AGENCY: BILLING CODE 4140–01–P Food and Drug Administration, HHS. Notice; reopening of the comment period. ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 The Food and Drug Administration (FDA) is reopening until September 15, 2010, the comment period for the notice that published in the Federal Register of Thursday, June 17, 2010 (75 FR 34463). In the notice, FDA requested input and comments from interested stakeholders on the agency’s oversight of laboratory developed tests (LDTs). FDA is reopening the comment period to update comments and to receive any new information. DATES: Submit either electronic or written comments and information by September 15, 2010. ADDRESSES: Submit electronic comments or information to https:// www.regulations.gov. Submit written comments or information to the Division of Dockets Management (HFA– 305), Food and Drug Administration, SUMMARY: E:\FR\FM\19AUN1.SGM 19AUN1

Agencies

[Federal Register Volume 75, Number 160 (Thursday, August 19, 2010)]
[Notices]
[Page 51280]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-20584]



[[Page 51280]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Biology of Macromolecular Assemblies.
    Date: September 1, 2010.
    Time: 2 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Rolf Menzel, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD 20892, 301-435-
0952, menzelro@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Cellular and Molecular Aspects of 
Neurodevelopment.
    Date: September 9, 2010.
    Time: 1 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Laurent Taupenot, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4811, MSC 7850, Bethesda, MD 
20892, 301-435-1203, taupenol@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA Panel: Investigations on Primary Immunodeficiency 
Diseases.
    Date: September 28, 2010.
    Time: 11 a.m. to 5 pm.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Scott Jakes, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD 20892, 301-495-
1506, jakesse@mail.nih.gov.

    Name of Committee: Immunology Integrated Review Group; Cellular 
and Molecular Immunology--A Study Section.
    Date: September 30-October 1, 2010.
    Time: 8:30 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The St. Regis Washington, DC, 923 16th Street, NW., 
Washington, DC 20006.
    Contact Person: David B. Winter, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 
Immunology IRG, 4th Floor, Rm. 4204, 6701 Rockledge Drive, RKII, 
Bethesda, MD 20892, 301-435-1152, dwinter@mail.nih.gov.

    Name of Committee: Immunology Integrated Review Group; 
Transplantation, Tolerance, and Tumor Immunology Study Section.
    Date: September 30-October 1, 2010.
    Time: 8:30 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Melrose Hotel, 2430 Pennsylvania Avenue, NW., 
Washington, DC 20037.
    Contact Person: Jin Huang, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4199, MSC 7812, Bethesda, MD 20892, 301-435-
1230, jh377p@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 10, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-20584 Filed 8-18-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.